Retractable Technologies (RVP) Research & Development (2010 - 2026)
Retractable Technologies' (RVP) quarterly Research & Development came in at $1.5 million in Q2 2026, down 7.64% on a YoY basis from $1.7 million in Q2 2025, and down 11.49% quarter-over-quarter from $1.7 million in Q1 2026.
Analysis
Retractable Technologies (RVP) Research & Development (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has reported Research & Development for 17 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Research & Development fell 7.64% year-over-year to $1.5 million; the trailing twelve-month figure through Jun 2026 stood at $6.8 million (up 10.04% YoY), and the FY2025 full-year result was $6.8 million, up 16.61% from the prior year.
- Research & Development declined to $1.5 million in Q2 2026 per RVP's latest filing, from $1.7 million in the prior quarter.
- Across five years, Research & Development topped out at $2.0 million in Q4 2025 and bottomed at $1.0 million in Q1 2022.
- Historically, Research & Development has averaged $1.5 million across 5 years, with a median of $1.5 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Research & Development fell 26.36% in 2022, then jumped 65.8% in 2025.
- Over 5 years, Research & Development stood at $1.3 million in 2022, then increased by 12.22% to $1.4 million in 2023, then fell by 17.54% to $1.2 million in 2024, then surged by 65.8% to $2.0 million in 2025, then dropped by 22.19% to $1.5 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $1.5 million, $1.7 million, and $2.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 258.00 Mn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | - |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 19.70 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 129.00 Mn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | 7.22 Mn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | - |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 577,000.00 |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 1.53 Mn |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 3,852.00 |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.53 Mn |
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Mar 31, 2022 | 1.02 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 1.02 Mn |